Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more
The FDA has proposed to include one additional bulk drug substance on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug and Cosmetic Act.
read more
Zydus is recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials after receiving several complaints of crystallization in vials.
read more
Catalent has signed an agreement with Cybin to apply Catalent’s proprietary Zydis ODT technology for the delivery of Cybin’s novel deuterated tryptamine.
read more
AGC Chemicals now offers small-molecule API contract manufacturing services.
read more
Wednesday, March 17, 2021
Bryant Ranch Prepack is voluntarily recalling in total 47 bottles of Spironolactone tablets to the consumer level.
read more
Vectura Group announced an expansion of its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, U.K.
read more
Debiopharm announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany for the development and commercialization of xevinapant.
read more
Wednesday, March 03, 2021
Grace has entered into a definitive agreement to acquire the Fine Chemistry Services business of Albemarle for approximately $570 million.
read more
The FDA issued an EUA for the third vaccine for the prevention of COVID-19.
read more
Monday, February 22, 2021
Wavelength Pharmaceuticals announced the acquisition of a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.
read more
Monday, February 22, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs under cGMP.
read more
Thursday, February 18, 2021
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Thursday, February 18, 2021
SCYNEXIS has entered into a licensing agreement and strategic partnership with Hansoh Pharmaceutical Group.
read more
Friday, February 12, 2021
AzurRx BioPharma has entered into an agreement with PPD for its trial evaluating micronized niclosamide for COVID-19-associated GI infections.
read more